Abstract Details
|
Jonadab Dos Santos Silva, MD, PhD
PRESENTER |
Dr. Dos Santos Silva has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Josefina Maranzano (McGill University, Montreal Neurological Institute) | The institution of Ms. Maranzano has received research support from Natural Sciences and Engineering Research Council of Canada. |
| Daniel Reich, MD, PhD (National Institutes of Health, Neuroimmunology Branch, NINDS) | Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to AAN interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to AAN interests or activities. |
| Erin S. Beck, MD (Icahn School of Medicine at Mount Sinai) | Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline. An immediate family member of Dr. Beck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmaceutical Corporation. An immediate family member of Dr. Beck has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Swedish Orphan Biovitrum AB. The institution of Dr. Beck has received research support from National Multiple Sclerosis Society. The institution of Dr. Beck has received research support from National Institutes of Health. The institution of Dr. Beck has received research support from United States Department of Defense. The institution of Dr. Beck has received research support from Consortium of Multiple Sclerosis Centers. Dr. Beck has received intellectual property interests from a discovery or technology relating to health care. |